Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Remebot is the commercial brand of Beijing Baihui Weikang Technology, a China-based medical robotics company focused on surgical robot systems for neurosurgery and dentistry. The company develops, manufactures, and sells image-guided robotic platforms that support minimally invasive procedures such as deep brain stimulation electrode placement, SEEG implantation, intracranial biopsy, puncture, and oral implant surgery. Its products combine surgical planning software, multimodal image fusion, navigation and positioning, and robotic execution to improve procedural precision and workflow. Remebot states that its systems are deployed broadly across China and have been used in tens of thousands of clinical procedures. The company appears to be a medtech/device business rather than a therapeutics developer, with commercialized hardware and software platforms rather than a drug pipeline.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Remebot.